{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:22:29Z","timestamp":1789752149794,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"am","delay-in-days":323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.rmed.2025.107991","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:17:26Z","timestamp":1739233046000},"page":"107991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Outcomes in lung transplant recipients on azathioprine compared to mycophenolate"],"prefix":"10.1016","volume":"239","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9596-7104","authenticated-orcid":false,"given":"David M.","family":"Sanborn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5389-8710","authenticated-orcid":false,"given":"Joelle N.","family":"Friesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1889-2524","authenticated-orcid":false,"given":"Hemang","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3219-165X","authenticated-orcid":false,"given":"Cassie C.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8859-4231","authenticated-orcid":false,"given":"Mark E.","family":"Wylam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8438-3261","authenticated-orcid":false,"given":"Steve G.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4612-1540","authenticated-orcid":false,"given":"John P.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5609-1488","authenticated-orcid":false,"given":"Sahar A.","family":"Saddoughi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1187-5059","authenticated-orcid":false,"given":"Kelly M.","family":"Pennington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.rmed.2025.107991_bib1","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.healun.2016.09.001","article-title":"The registry of the international society for Heart and lung transplantation: thirty-third adult lung and heart-lung transplant report-2016; focus theme: primary diagnostic indications for transplant","volume":"35","author":"Yusen","year":"2016","journal-title":"J. Heart Lung Transplant."},{"issue":"1","key":"10.1016\/j.rmed.2025.107991_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/13696998.2022.2033050","article-title":"Mean lifetime survival estimates following solid organ transplantation in the US and UK","volume":"25","author":"Graham","year":"2022","journal-title":"J. Med. Econ."},{"issue":"10","key":"10.1016\/j.rmed.2025.107991_bib3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.healun.2022.08.007","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-ninth adult lung transplantation report-2022; focus on lung transplant recipients with chronic obstructive pulmonary disease","volume":"41","author":"Perch","year":"2022","journal-title":"J. Heart Lung Transplant."},{"issue":"1","key":"10.1016\/j.rmed.2025.107991_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1513\/pats.200808-096GO","article-title":"Immunosuppression for lung transplantation","volume":"6","author":"Bhorade","year":"2009","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"12","key":"10.1016\/j.rmed.2025.107991_bib5","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1097\/00007890-200106270-00012","article-title":"Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection","volume":"71","author":"Palmer","year":"2001","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.rmed.2025.107991_bib6","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/01.tp.0000202755.33883.61","article-title":"Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients","volume":"81","author":"McNeil","year":"2006","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.rmed.2025.107991_bib7","article-title":"Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients","author":"Penninga","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"Issue 4","key":"10.1016\/j.rmed.2025.107991_bib8","article-title":"Tacrolimus vs cyclosporine as primary maintenance immunosuppressant for lung transplant recipients: a systematic review and meta-analysis","volume":"158","author":"Haddad","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2025.107991_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J. Biomed. Inf."},{"issue":"2","key":"10.1016\/j.rmed.2025.107991_bib10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inf."},{"issue":"1","key":"10.1016\/j.rmed.2025.107991_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/ajt.15561","article-title":"The impact of first untreated subclinical minimal acute rejection on risk for chronic lung allograft dysfunction or death after lung transplantation","volume":"20","author":"Levy","year":"2020","journal-title":"Am. J. Transplant."},{"issue":"12","key":"10.1016\/j.rmed.2025.107991_bib12","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","article-title":"Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection","volume":"26","author":"Stewart","year":"2007","journal-title":"J. Heart Lung Transplant."},{"issue":"5","key":"10.1016\/j.rmed.2025.107991_bib13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT","volume":"38","author":"Verleden","year":"2019","journal-title":"J. Heart Lung Transplant."},{"issue":"8","key":"10.1016\/j.rmed.2025.107991_bib14","first-page":"768","article-title":"Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience","volume":"17","author":"Ross","year":"1998","journal-title":"J. Heart Lung Transplant."},{"issue":"5","key":"10.1016\/j.rmed.2025.107991_bib15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S1053-2498(99)00004-2","article-title":"Comparison between mycophenolate mofetil- and azathioprine-based immunosuppressions in clinical lung transplantation","volume":"18","author":"Zuckermann","year":"1999","journal-title":"J. Heart Lung Transplant."},{"issue":"5","key":"10.1016\/j.rmed.2025.107991_bib16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pupt.2010.04.004","article-title":"Mycophenolate mofetil reduces alveolar inflammation, acute rejection and graft loss due to bronchiolitis obliterans syndrome after lung transplantation","volume":"23","author":"Speich","year":"2010","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.rmed.2025.107991_bib17","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0003-4975(97)00845-X","article-title":"Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantation","volume":"64","author":"Whyte","year":"1997","journal-title":"Ann. Thorac. Surg."},{"issue":"1","key":"10.1016\/j.rmed.2025.107991_bib18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0041-1345(01)02707-5","article-title":"Preliminary results of rescue therapy with tacrolimus and mycophenolate mofetil in lung transplanted patients with bronchiolitis obliterans","volume":"34","author":"Roman","year":"2002","journal-title":"Transplant. Proc."},{"issue":"12","key":"10.1016\/j.rmed.2025.107991_bib19","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1111\/ajt.13863","article-title":"Azathioprine and risk of skin cancer in organ transplant recipients: systematic review and meta-analysis","volume":"16","author":"Jiyad","year":"2016","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.rmed.2025.107991_bib20","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.healun.2018.03.012","article-title":"Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation","volume":"37","author":"Vos","year":"2018","journal-title":"J. Heart Lung Transplant."},{"issue":"10","key":"10.1016\/j.rmed.2025.107991_bib21","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2165\/00019053-200220100-00004","article-title":"Mycophenolate mofetil: a pharmacoeconomic review of its use in solid organ transplantation","volume":"20","author":"Young","year":"2002","journal-title":"Pharmacoeconomics"},{"issue":"1\u20132","key":"10.1016\/j.rmed.2025.107991_bib22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0041-1345(98)01624-8","article-title":"One-year, single-center cost analysis of mycophenolate mofetil versus azathioprine following cadaveric renal transplantation","volume":"31","author":"Khosla","year":"1999","journal-title":"Transplant. Proc."},{"issue":"33","key":"10.1016\/j.rmed.2025.107991_bib23","first-page":"1577","article-title":"[Economic contribution of mofetil mycofenolate as preventive immunosuppressive treatment after renal transplantation from cadaver]","volume":"25","author":"Louis-Touizer","year":"1996","journal-title":"Presse Med."},{"issue":"3B Suppl","key":"10.1016\/j.rmed.2025.107991_bib24","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.1016\/S0041-1345(99)00097-4","article-title":"Ten-year cost effectiveness of alternative immunosuppression regimens in cadaveric renal transplantation","volume":"31","author":"Schnitzler","year":"1999","journal-title":"Transplant. Proc."},{"issue":"1","key":"10.1016\/j.rmed.2025.107991_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15190","article-title":"Cost minimization analysis of mainstay treatments in cutaneous lupus erythematous","volume":"35","author":"Rizvi","year":"2022","journal-title":"Dermatol. Ther."},{"issue":"1","key":"10.1016\/j.rmed.2025.107991_bib26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3899\/jrheum.080517","article-title":"Cost comparison between mycophenolate mofetil and cyclophosphamide-azathioprine in the treatment of lupus nephritis","volume":"36","author":"Tse","year":"2009","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.rmed.2025.107991_bib27","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1053-2498(00)00251-5","article-title":"A model for analyzing the cost of the main clinical events after lung transplantation","volume":"20","author":"Sharples","year":"2001","journal-title":"J. Heart Lung Transplant."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125000538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125000538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T08:17:06Z","timestamp":1741335426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125000538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":27,"alternative-id":["S0954611125000538"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.107991","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes in lung transplant recipients on azathioprine compared to mycophenolate","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.107991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107991"}}